Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning.
第一作者:
Elisabeth,Schwaiger
第一单位:
Division of Transplantation, Department of Surgery, Vienna General Hospital, Medical University of Vienna, Austria.
作者:
主题词
动物(Animals);骨髓移植(Bone Marrow Transplantation);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);女(雌)性(Female);小鼠(Mice);小鼠, 近交C3H(Mice, Inbred C3H);小鼠, 近交C57BL(Mice, Inbred C57BL);寡肽类(Oligopeptides);吡嗪类(Pyrazines);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);三唑类(Triazoles)
DOI
10.1016/j.exphem.2011.10.010
PMID
22085453
发布时间
2021-10-21
- 浏览9
Experimental hematology
97-106页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



